Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGF anticorps (Extracellular Domain)

L’anticorps Lapin Polyclonal anti-EGF a été validé pour WB, IHC, ELISA, IHC (p) et Func. Il convient pour détecter EGF dans des échantillons de Humain.
N° du produit ABIN205919

Aperçu rapide pour EGF anticorps (Extracellular Domain) (ABIN205919)

Antigène

Voir toutes EGF Anticorps
EGF (Epidermal Growth Factor (EGF))

Reactivité

  • 147
  • 90
  • 49
  • 12
  • 12
  • 6
  • 4
  • 1
  • 1
Humain

Hôte

  • 212
  • 35
  • 10
  • 2
  • 2
  • 1
Lapin

Clonalité

  • 215
  • 46
Polyclonal

Conjugué

  • 121
  • 33
  • 20
  • 13
  • 8
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp EGF est non-conjugé

Application

  • 199
  • 84
  • 71
  • 53
  • 53
  • 34
  • 26
  • 26
  • 25
  • 16
  • 15
  • 13
  • 10
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Functional Studies (Func)
  • Épitope

    • 45
    • 16
    • 8
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Specificité

    Recognizes human Epidermal Growth Factor, a potent stimulator and regulator of the proliferation of epidermal and epithelial cells, expressed by a variety of cells. The effects of EGF are initiated through tyrosine kinase activity, following the binding of EGF to the extracellular domain of the ~170 kD EGF receptor (EGFR), which also binds other EGF-like ligands with high affinity, including TGF-a (transforming growth factor alpha), VGF (vaccinia virus growth factor) and Betacellulin, expressed in the pancreas, small intestine and by certain tumor cells. Receptor activation through EGF binding triggers several signal transduction pathways, including the JAK/STAT and P13K/AKT pathways.

    Purification

    Purified

    Immunogène

    Recombinant human EGF.

    Type of Immunogen: Recombinant protein

    Isotype

    IgG
  • Indications d'application

    Approved: ELISA (0.5 - 2 μg/mL), Func (0.25 - 0.35 μg/mL), IHC, IHC-P (0.25 - 1 μg/mL), WB (0.1 - 0.2 μg/mL)

    Usage: Immunohistochemistry: This product requires protein digestion pre-treatment of paraffin sections e. g. trypsin or pronase. Histology Positive Control Tissue: Human skin ELISA: LS-C42950 may be used in an indirect ELISA system or as a capture antibody in a sandwich ELISA for human EGF in combination with LS-C42951 as a detection reagent.

    Commentaires

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Distilled Water. For long term storage the addition of 0.09 % sodium azide is recommended. For functional studies do not add azide.

    Concentration

    Lot specific

    Buffer

    Lyophilized, PBS,  pH 7.4.
  • Antigène

    EGF (Epidermal Growth Factor (EGF))

    Autre désignation

    EGF

    Sujet

    Name/Gene ID: EGF

    Synonyms: EGF, Beta-urogastrone, HOMG4, URG, Epidermal growth factor, Pro-epidermal growth factor

    ID gène

    1950

    Pathways

    Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Vous êtes ici:
Chat with us!